Feasibility of Chlamydia trachomatis screening and treatment in pregnant women in Lima, Peru: A prospective study in two large urban hospitals

Sexually Transmitted Infections

Volumn 91, Issue 1, 2015, Pages 7-10

  Cabeza, Jeanne ^a,g   García, Patricia J ^b   Segura, Eddy ^a   García, Pedro ^c   Escudero, Francisco ^d   La Rosa, Sayda ^b   León, Segundo ^e,f   Klausner, Jeffrey D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c INSTITUTO NACIONAL MATERNO PERINATAL   (Peru)

^d HOSPITAL NACIONAL ARZOBISPO LOAYZA   (Peru)

^e UNIVERSITY OF WASHINGTON   (United States)

^f Universidad Nacional Mayor de San Marcos   (Peru)

^g Center for AIDS Research and Education (CARE)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COUNSELING; DIRECTLY OBSERVED THERAPY; FEASIBILITY STUDY; FEMALE; GESTATIONAL AGE; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PERU; PREGNANT WOMAN; PRENATAL PERIOD; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HOSPITAL; RETREATMENT; SCREENING TEST; TREATMENT DURATION; URBAN AREA; CHLAMYDIA INFECTIONS; COST BENEFIT ANALYSIS; HOSPITAL; ISOLATION AND PURIFICATION; MASS SCREENING; MEDICATION COMPLIANCE; MICROBIOLOGY; MIDDLE AGED; PATIENT ATTITUDE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROCEDURES; TREATMENT OUTCOME; VAGINA; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COST-BENEFIT ANALYSIS; FEASIBILITY STUDIES; FEMALE; HOSPITALS, URBAN; HUMANS; MASS SCREENING; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PERU; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VAGINA; YOUNG ADULT;

EID: 84928190241     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2014-051531     Document Type: Article

References (10)

1. Meyers DS, Halvorson H, Luckhaupt S. Screening for chlamydial infection: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med 2007;147:135-42.
2. Paul KJ, García PJ, Giesel AE, et al. Generation C: prevalence of and risk factors for Chlamydia trachomatis among adolescents and young women in Lima, Peru. J Women's Health 2009;18:1419-24.
3. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010;59:1-116.
4. Association of Public Health Laboratories and Centers for Disease control and Prevention. Laboratory diagnostic testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Expert consultation meeting summary report. 13-15 January 2009, Atlanta, GA.
5. Modongo C, Zetola NM, Pandouri M, et al. Has the answer to diagnosing TB in resource-limited settings been found? MLO Med Lab Obs 2011;43:25.
6. Hislop J, Quayyum Z, Flett G, et al. Systematic review of the clinical effectiveness and cost effectiveness of rapid point-of-care tests for the detection of genital chlamydia infection in women and men. Health Technol Assess 2010;14:1-97.
7. Whittington WL, Kent C, Kissinger P. Determinants of persistent and recurrent Chlamydia trachomatis infection in young women. Sex Transm Dis 2001;28:117-23.
8. Wang SA, Papp JR, Stamm WE, et al. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. J Infect Dis 2005;191:917-23.
9. Williams J, Offner S, Batteiger B, et al. Duration of polymerase chain reaction-detectable DNA after treatment of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis infections in women. Sex Transm Dis 2014;41:215-9.
10. Alam N, Chamot E, Vermund S, et al . Partner notification for sexually transmitted infections in developing countries: a systematic review. BMC Public Health 2010;10:19.